<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Infective Endocarditis</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Infective Endocarditis</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <!-- <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div> -->
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
<br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <h4>Definition</h4>
            <p><b>Infective Endocarditis</b> is the microbial infection of the heart valve (native or prosthetic), the lining of a cardiac chamber or blood vessel, or a congenital anomaly (e.g., ventricular septal defect).</p>
            
            <h4>Causative Organisms</h4>
            <ul>
              <li>Usually bacteria</li>
              <li><i>Rickettsia</i> (e.g., <i>Coxiella burnetii</i> endocarditis)</li>
              <li>Chlamydia</li>
              <li>Fungi</li>
            </ul>
            
            <h4>General Characteristics</h4>
            <ul>
              <li>Left-sided endocarditis is more common than right-sided (<b>Left > Right</b>).</li>
              <li>The mitral valve is affected more often than the aortic valve (<b>Mitral > Aortic</b>).</li>
              <li>Regurgitant valves are affected more frequently than stenotic valves (<b>Regurgitant > Stenotic</b>).</li>
            </ul>
            
            <h4>Prosthetic Valve Endocarditis</h4>
            <ul>
              <li><b>Early:</b> Occurs within 60 days post-surgery. Most commonly caused by <i>Staphylococcus</i>.</li>
              <li><b>Late:</b> Occurs after 60 days post-surgery. Most commonly caused by <i>Streptococcus</i>.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Classification/Types</a>
          </h2>
        </header>
        <div class='body'>
            <p><b>Infective Endocarditis (IE)</b>: An infection of the heart‚Äôs endocardial surface.</p>
            
            <h4>Main Classification</h4>
            <ul>
              <li><b>Native Valve IE</b></li>
              <li><b>Prosthetic Valve IE</b></li>
            </ul>
            
            <h4>Other classifications</h4>
            <ul>
              <li><b>Intravenous Drug Abuse (IVDA) IE</b></li>
              <li><b>Nosocomial IE</b></li>
            </ul>
            
            <h4>Types of Infective Endocarditis</h4>
            <h4>1. Acute Infective Endocarditis</h4>
            <ul>
              <li><b>Toxic presentation</b></li>
              <li>Progressive valve destruction and metastatic infection developing within days to weeks</li>
              <li>Most commonly caused by <i>Staphylococcus aureus</i></li>
            </ul>
            
            <h4>2. Subacute Infective Endocarditis</h4>
            <ul>
              <li><b>Mild toxicity</b></li>
              <li>Presentation occurs over weeks to months</li>
              <li>Rarely leads to metastatic infection</li>
              <li>Most commonly caused by <i>Streptococcus viridans</i> or <i>Enterococcus</i></li>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Pathophysiology</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li><strong>Preexisting endocardial damage</strong>
                <ul>
                  <li><strong>Virulent organisms</strong> (e.g., staphylococci) cause endocarditis in normal heart valves.</li>
                  <li><strong>Tricuspid valve endocarditis</strong> is common in <strong>intravenous drug users (IVDU)</strong>.</li>
                </ul>
              </li>
            
              <li><strong>Vulnerable cardiac lesions</strong>
                <ul>
                  <li>A wide variety of <strong>acquired and congenital cardiac lesions</strong> are susceptible to endocarditis.</li>
                  <li>Lesions associated with <strong>high-pressure jets of blood</strong>, such as those in <strong>VSD</strong>, <strong>MR</strong>, <strong>AR</strong>, and <strong>stenotic lesions</strong>, are more prone to endocarditis.</li>
                  <li><strong>Low-pressure lesions</strong>, like large <strong>ASD</strong>, are less likely to cause endocarditis.</li>
                </ul>
              </li>
            
              <li><strong>Breaks in skin</strong>
                <ul>
                  <li>Endocarditis can occur at sites of <strong>endocardial damage</strong>.</li>
                  <li>Areas of damage attract <strong>platelets</strong> and <strong>fibrin</strong>, which provide a platform for bloodborne organisms to colonize.</li>
                </ul>
              </li>
            
              <li><strong>Infection progression</strong>
                <ul>
                  <li>Once an infection is established, <strong>vegetation</strong> consisting of organisms, fibrin, and platelets grows and becomes large.</li>
                  <li>Vegetations may erode into the underlying <strong>myocardium</strong>, producing <strong>abscesses</strong> (ring abscess).</li>
                  <li><strong>Perforation</strong> or disruption of <strong>chordae</strong> may occur.</li>
                </ul>
              </li>
            
              <li><strong>Embolization</strong>
                <ul>
                  <li>Vegetation can break away and embolize to distant organs, causing further damage.</li>
                </ul>
              </li>
            
              <li><strong>Extra-cardiac manifestations</strong>
                <ul>
                  <li>Examples include <strong>vasculitis</strong>, <strong>skin lesions</strong>, and emboli or immune complex deposits.</li>
                  <li>At postmortem:
                    <ul>
                      <li><strong>Infarction</strong> of kidney and spleen.</li>
                      <li><strong>Immune complex glomerulonephritis (GN)</strong>.</li>
                    </ul>
                  </li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Aetiology</a>
          </h2>
        </header>
        <div class='body'>

            <ul>
              <li>The majority of cases of infective endocarditis (IE) are caused by <strong>gram-positive bacteria</strong>.</li>
              <li><strong>Staphylococcus aureus (SA)</strong> is now more common (31-54%) than oral <strong>Streptococci</strong>.</li>
              <li><strong>Methicillin-sensitive SA</strong> is more frequent in <strong>community-acquired IE</strong>, infects mainly <strong>native valves</strong>, and is associated with <strong>bacteraemia of unknown origin</strong>.</li>
              <li><strong>MRSA (Methicillin-resistant Staphylococcus aureus)</strong> is more related to <strong>nosocomial infections</strong>, <strong>wound infections</strong>, <strong>permanent IV catheters</strong>, or <strong>surgery in the previous 6 months</strong>.</li>
              <li><strong>Strep viridans</strong> is now less common (12-26%) but difficult to isolate and confers partial resistance to antibiotics.</li>
              <li><strong>Coagulase-negative Staphylococci</strong> were the main cause of <strong>prosthetic valve endocarditis</strong> in the past, especially within the first 6-12 months after valve surgery. <strong>MRSA</strong> is now more common.</li>
              <li><strong>Enterococci</strong></li>
              <li><strong>HACEK group:</strong>
                <ul>
                  <li><strong>Haemophilus group</strong></li>
                  <li><strong>Actinobacillus group</strong></li>
                  <li><strong>Cardiobacterium hominis</strong></li>
                  <li><strong>Eikenella corrodens</strong></li>
                  <li><strong>Kingella kingae</strong></li>
                  <li>All are commensals in the <strong>oral cavity</strong>.</li>
                </ul>
              </li>
            </ul>
            
            <h4>Other Causes</h4>
            
            <ul>
              <li><strong>Candida</strong> and <strong>Aspergillus species</strong> cause the majority of <strong>fungal IE</strong> (1-3% of all IE cases).</li>
              <li><strong>Risk factors:</strong> Patients with <strong>IV drug use</strong>, <strong>prosthetic valves</strong>, or <strong>long-term central venous catheters</strong> are more likely to develop <strong>fungal IE</strong>.</li>
              <li><strong>Fungal IE</strong> should be considered in the presence of <strong>bulky vegetations</strong>, <strong>metastatic infection</strong>, <strong>perivalvular invasion</strong>, or <strong>embolization to large blood vessels</strong> despite negative blood cultures (BC).</li>
              <li>In 10-15% of all cases of endocarditis, no organism can be isolated from blood culture (referred to as <strong>"culture-negative" endocarditis</strong>).</li>
              <li>When BC-negative IE is suspected, other organisms to consider include:
                <ul>
                  <li><strong>Coxiella burnetti</strong></li>
                  <li><strong>Legionella spp</strong></li>
                  <li><strong>Brucella spp</strong></li>
                  <li><strong>Bartonella spp</strong></li>
                  <li><strong>Chlamydiae spp.</strong></li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Findings</a>
          </h2>
        </header>
        <div class='body'>
            <p><strong>Symptoms & Signs</strong></p>
            <ul>
              <li><strong>Febrile illness</strong></li>
              <li><strong>Nonspecific symptoms</strong> such as:
                <ul>
                  <li>Cough</li>
                  <li>Dyspnea</li>
                  <li>Arthralgia or arthritis</li>
                  <li>Diarrhea</li>
                  <li>Abdominal pain</li>
                </ul>
              </li>
              <li><strong>Cerebral emboli</strong></li>
              <li><strong>Subconjunctival hemorrhage</strong></li>
              <li><strong>Roth‚Äôs spot in fundi</strong></li>
              <li><strong>Petechial hemorrhage</strong> in mucous membranes & fundi</li>
              <li><strong>Varying murmurs</strong></li>
              <li><strong>Conduction disorders</strong></li>
              <li><strong>Cardiac failure</strong></li>
              <li><strong>Splenomegaly</strong></li>
              <li><strong>Hematuria</strong></li>
              <li><strong>Osler‚Äôs nodes</strong></li>
              <li><strong>Digital clubbing</strong></li>
              <li><strong>Splinter hemorrhages</strong></li>
              <li><strong>Janeway lesions</strong></li>
              <li><strong>Systemic emboli</strong></li>
              <li><strong>Petechial rash</strong></li>
            </ul>
            
            <h4>Splinter Hemorrhages</h4>
            <ul>
              <li><strong>Nonspecific</strong></li>
              <li><strong>Nonblanching</strong></li>
              <li><strong>Linear reddish-brown lesions</strong> found under the nail bed</li>
              <li>Usually do NOT extend the entire length of the nail</li>
            </ul>
            
            <h4>Subconjunctival Hemorrhages</h4>
            <ul>
              <li>Often associated with embolic phenomena</li>
            </ul>
            
            <h4>Janeway Lesions</h4>
            <ul>
              <li><strong>More specific</strong></li>
              <li><strong>Erythematous, blanching macules</strong></li>
              <li><strong>Nonpainful</strong></li>
              <li>Located on palms and soles</li>
            </ul>
            
            <h4>Osler Nodes</h4>
            <ul>
              <li><strong>More specific</strong></li>
              <li><strong>Painful and erythematous nodules</strong></li>
              <li>Located on the pulp of fingers and toes</li>
              <li><strong>More common in subacute IE</strong></li>
            </ul>
            
            <h4>Roth Spots</h4>
            <ul>
              <li>Retinal findings, indicative of embolic events</li>
            </ul>
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Diagnosis</a>
          </h2>
        </header>
        <div class='body'>
            <p><strong>Essentials of Diagnosis</strong></p>
            <ul>
              <li><strong>Preexisting organic heart lesion</strong></li>
              <li><strong>Fever</strong></li>
              <li><strong>New or changing heart murmur</strong></li>
              <li><strong>Evidence of systemic emboli</strong></li>
              <li><strong>Positive blood culture</strong></li>
              <li><strong>Evidence of vegetation on echocardiography</strong></li>
            </ul>
            
            <h4>The Modified Duke Criteria</h4>
            <p>The <strong>Modified Duke Criteria</strong> is based on clinical, microbiological, and echocardiographic findings, providing high sensitivity and specificity (~80%) for the diagnosis of infective endocarditis (IE) when applied to patients with native valve IE and positive blood cultures.</p>
            
            <h4>Major Diagnostic Criteria</h4>
            <ol>
              <li><strong>Blood culture positive for IE</strong>
                <ul>
                  <li>Typical microorganisms consistent with IE from 2 separate blood cultures:
                    <ul>
                      <li>Viridans streptococci</li>
                      <li>Streptococcus bovis</li>
                      <li>HACEK group</li>
                      <li>Staphylococcus aureus</li>
                      <li>Community-acquired enterococci in the absence of a primary focus</li>
                      <li>Or microorganisms consistent with IE from persistently positive blood cultures defined as follows:
                        <ul>
                          <li>At least 2 positive cultures of blood samples drawn >12 hours apart</li>
                          <li>Or all 3 or a majority of ‚â•4 separate blood cultures (with first and last sample drawn at least 1 hour apart)</li>
                        </ul>
                      </li>
                    </ul>
                  </li>
                  <li>Single positive blood culture for <em>Coxiella burnetii</em> or anti-phase 1 IgG antibody titer ‚â•1:800</li>
                </ul>
              </li>
              <li><strong>Evidence of endocardial involvement by echocardiography</strong>
                <ul>
                  <li><strong>Echocardiogram positive for IE</strong>
                    <ul>
                      <li>TEE (Transesophageal Echocardiography) is recommended for patients with prosthetic valves, rated at least possible IE by clinical criteria, or complicated IE (e.g., paravalvular abscess).</li>
                      <li>TTE (Transthoracic Echocardiography) is the first test for other patients.</li>
                      <li>Defined as:
                        <ul>
                          <li>Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation.</li>
                          <li>Abscess</li>
                          <li>New partial dehiscence of prosthetic valve or new valvular regurgitation (worsening or changing pre-existing murmur not sufficient)</li>
                        </ul>
                      </li>
                    </ul>
                  </li>
                </ul>
              </li>
            </ol>
            
            <h4>Minor Diagnostic Criteria</h4>
            <ol>
              <li><strong>Predisposing heart condition or intravenous drug use</strong></li>
              <li><strong>Temperature >38¬∞C (100.4¬∞F)</strong></li>
              <li><strong>Vascular phenomena</strong>:
                <ul>
                  <li>Arterial emboli</li>
                  <li>Pulmonary infarcts</li>
                  <li>Mycotic aneurysms</li>
                  <li>Intracranial bleed</li>
                  <li>Conjunctival hemorrhages</li>
                  <li>Janeway lesions</li>
                </ul>
              </li>
              <li><strong>Immunologic phenomena</strong>:
                <ul>
                  <li>Glomerulonephritis</li>
                  <li>Osler nodes</li>
                  <li>Roth spots</li>
                  <li>Rheumatoid factor</li>
                </ul>
              </li>
              <li><strong>Microbiological evidence</strong>:
                <ul>
                  <li>Positive blood culture but does not meet a major criterion as noted above, or serological evidence of active infection with an organism consistent with endocarditis (excluding coagulase-negative staphylococci and other common contaminants)</li>
                </ul>
              </li>
            </ol>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Investigations </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Blood culture</strong>
                <ul>
                  <li>Drawn from three different sites at 1-hour intervals.</li>
                  <li>50% of fungal endocarditis cases may result in negative blood cultures.</li>
                  <li>PCR has been proposed in these cases.</li>
                  <li>PCR of excised valve tissue or embolic material should be performed in culture-negative IE (in cases of valve surgery or embolectomy).</li>
                </ul>
              </li>
              <li><strong>ESR (Erythrocyte Sedimentation Rate)</strong></li>
              <li><strong>CRP (C-Reactive Protein)</strong></li>
              <li><strong>CXR (Chest X-ray) - PA View</strong></li>
              <li><strong>ECG (Electrocardiogram)</strong></li>
              <li><strong>Echocardiography</strong>
                <ul>
                  <li><strong>Transthoracic Echocardiography (TTE)</strong>: Sensitivity for detecting vegetation is 65% (with >3‚Äì5mm of vegetation).</li>
                  <li><strong>Transesophageal Echocardiography (TEE)</strong>: Sensitivity for detecting vegetation is 90% (with >1‚Äì1.5mm of vegetation).</li>
                </ul>
              </li>
            </ul>
            
            <h4>Echocardiography Findings</h4>
            <ul>
              <li><strong>Vegetation</strong>: Hallmark lesion of IE</li>
              <li><strong>Periannular abscess</strong></li>
              <li><strong>New dehiscence of valvular prosthesis</strong></li>
              <li><strong>Aortic/mitral regurgitation</strong>: Secondary to valvular necrosis, perforation, or prolapse</li>
              <li>Approximately 50-60% of patients with IE develop heart failure secondary to valvular destruction and require early surgery (mortality without surgery ~80%)</li>
            </ul>
            
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Complications </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Damage to valves and heart</strong></li>
              <li><strong>Embolic episodes</strong></li>
              <li><strong>Regurgitations</strong></li>
              <li><strong>Extension of infection to myocardium</strong></li>
              <li><strong>Abscess</strong></li>
              <li><strong>Conduction disorders</strong></li>
              <li><strong>Pulmonary abscesses</strong></li>
            </ul>
            
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'> </a>
          </h2>
        </header>
        <div class='body'>
            <h4>Prophylaxis</h4>
            <ol>
              <li><strong>Prosthetic cardiac valves</strong>, including transcatheter-implanted prostheses and homografts.</li>
              <li><strong>Prosthetic material used for cardiac valve repair</strong>, such as annuloplasty rings and chords.</li>
              <li><strong>Previous IE</strong>.</li>
              <li><strong>Unrepaired cyanotic congenital heart disease</strong> or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device.</li>
              <li><strong>Cardiac transplant with valve regurgitation</strong> due to a previous condition.</li>
            </ol>
            
            <h4>Regimen</h4>
            <p><strong>Single dose 30 to 60 minutes before procedure</strong></p>
            
            <br>
            
            <table class="note-table">
              <thead>
                <tr>
                  <th><strong>Situation</strong></th>
                  <th><strong>Agent</strong></th>
                  <th><strong>Adults</strong></th>
                  <th><strong>Children</strong></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Unable to take oral medication</td>
                  <td>Ampicillin</td>
                  <td>2 g IM or IV</td>
                  <td>50 mg/kg IM or IV</td>
                </tr>
                <tr>
                  <td>Oral</td>
                  <td>Amoxicillin</td>
                  <td>2 g</td>
                  <td>50 mg/kg</td>
                </tr>
                <tr>
                  <td>Unable to take oral medication</td>
                  <td>Cefazolin or Ceftriaxone</td>
                  <td>1 g IM or IV</td>
                  <td>50 mg/kg IM or IV</td>
                </tr>
                <tr>
                  <td>Allergic to penicillins or ampicillin (oral)</td>
                  <td>Cephalexin</td>
                  <td>2 g</td>
                  <td>50 mg/kg</td>
                </tr>
                <tr>
                  <td>Allergic to penicillins or ampicillin (oral)</td>
                  <td>Clindamycin</td>
                  <td>600 mg</td>
                  <td>20 mg/kg</td>
                </tr>
                <tr>
                  <td>Allergic to penicillins or ampicillin (oral)</td>
                  <td>Azithromycin or Clarithromycin</td>
                  <td>500 mg</td>
                  <td>15 mg/kg</td>
                </tr>
                <tr>
                  <td>Allergic to penicillins or ampicillin & unable to take oral medication</td>
                  <td>Cefazolin or Ceftriaxone</td>
                  <td>1 g IM or IV</td>
                  <td>50 mg/kg IM or IV</td>
                </tr>
                <tr>
                  <td>Allergic to penicillins or ampicillin & unable to take oral medication</td>
                  <td>Clindamycin</td>
                  <td>600 mg IV or IM</td>
                  <td>20 mg/kg IV or IM</td>
                </tr>
              </tbody>
            </table>
            
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'> Treatment</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>Relies on the combination of prolonged bactericidal antimicrobial therapy and, in about half of patients, surgical eradication of infected tissues.</li>
              <li>Drug treatment of prosthetic valve endocarditis (PVE) should last longer (at least 6 weeks) compared to native valve endocarditis (NVE), which lasts 2-6 weeks.</li>
              <li>The first day of treatment should begin with effective antibiotic therapy, not on the day of surgery.</li>
            </ul>
            
            <br>

            <h4>Empirical Treatment of IE in Acute Severely Ill Patients (Before Pathogen Identification)</h4>
            <table class="note-table">
              <thead>
                <tr>
                  <th><strong>Condition</strong></th>
                  <th><strong>Class Level</strong></th>
                  <th><strong>Antibiotic</strong></th>
                  <th><strong>Dosage</strong></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Community Acquired NVE or Late PVE</td>
                  <td>IIa C</td>
                  <td>Ampicillin</td>
                  <td>12 gm per day IV in 4-6 divided doses</td>
                </tr>
                <tr>
                  <td></td>
                  <td></td>
                  <td>Flucloxacillin/Cloxacillin</td>
                  <td>12 gm per day IV in 4-6 divided doses</td>
                </tr>
                <tr>
                  <td></td>
                  <td></td>
                  <td>Gentamicin</td>
                  <td>3 mg/kg/day IV or IM in 1 dose</td>
                </tr>
                <tr>
                  <td></td>
                  <td>IIb C</td>
                  <td>Vancomycin</td>
                  <td>30 mg/kg/day IV in 2-3 divided doses</td>
                </tr>
                <tr>
                  <td></td>
                  <td></td>
                  <td>Gentamicin</td>
                  <td>3 mg/kg/day IV or IM in 1 dose</td>
                </tr>
                <tr>
                  <td>Early PVE or Nosocomial and Non-Nosocomial Healthcare Associated Endocarditis</td>
                  <td>IIb C</td>
                  <td>Vancomycin</td>
                  <td>30 mg/kg/day IV in 2-3 divided doses</td>
                </tr>
                <tr>
                  <td></td>
                  <td></td>
                  <td>Gentamicin</td>
                  <td>3 mg/kg/day IV or IM in 1 dose</td>
                </tr>
                <tr>
                  <td></td>
                  <td></td>
                  <td>Rifampicin</td>
                  <td>900-1200 mg IV or orally in 2-3 divided doses</td>
                </tr>
              </tbody>
            </table>
            
            <h4>Antibiotics</h4>
            <ul>
              <li>Empirical treatment typically involves flucloxacillin & gentamicin as the first line.</li>
              <li>Treatment is adjusted according to microbiological culture and sensitivity (MCS).</li>
              <li>Vancomycin is used in patients with intracardiac prosthetic material or suspected MRSA.</li>
              <li>Benzylpenicillin is the first choice for Streptococcus or Enterococcus penicillin-susceptible strains.</li>
              <li>For vancomycin-resistant MRSA, teicoplanin, lipopeptide daptomycin, or oxazolidones (linezolid) are recommended.</li>
            </ul>
            
            <h4>Fungal IE</h4>
            <ul>
              <li>Fungal endocarditis usually requires surgery.</li>
              <li>Amphotericin B does not penetrate well into vegetations but is used successfully against Candida endocarditis.</li>
              <li>Fluconazole is fungistatic and only active against Candida spp.</li>
              <li>Caspofungin is typically fungicidal for Candida spp., but its penetration into vegetations is unknown.</li>
            </ul>
            
            <h4>Treatment Course</h4>
            <ul>
              <li>IV antibiotics are normally continued for 4-6 weeks, with the goal of sterilizing the vegetations.</li>
              <li>Infectious Disease (ID) specialists should be involved in blood culture-negative (BC-ve) IE cases.</li>
            </ul>
            
            <h4>Treatment Organism Specific</h4>
            <ul>
              <li>Specific treatment should be adjusted based on the identified organism.</li>
            </ul>
            
            <h4>Surgery</h4>
            <ul>
              <li>Antimicrobial therapy can offer curative treatment in ~50% of cases.</li>
              <li>The other 50% of patients require surgery.</li>
              <li>The surgical goal is valve repair, but most patients require valve replacement.</li>
              <li>Patients with IE, large vegetations, intracardiac abscesses (9-14%), or persisting infection (9-11%) almost always require surgery.</li>
            </ul>
            
        </div>
      </section>





      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <!-- <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div> -->

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <!-- <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div> -->
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>

<!-- Floating TOC Button -->
<div id="toc-button" class="floating-toc-button">
  Table of Contents
</div>

<!-- Expandable TOC Panel -->
<div id="toc-panel" class="toc-panel">
  <div id="toc-panel-content">
      <h4>Table of Contents</h4>
      <ol id="dynamic-toc"></ol>
  </div>
</div>



<script>
// Dynamically generate TOC from <h2> headings within <section> elements
  const tocList = document.getElementById('dynamic-toc');
const sections = document.querySelectorAll('section');
const tocButton = document.getElementById('toc-button');
const tocPanel = document.getElementById('toc-panel');

// Generate Table of Contents
sections.forEach(section => {
    const headings = section.querySelectorAll('h2');
    headings.forEach(heading => {
        const headingAnchor = heading.querySelector('a');
        if (headingAnchor && headingAnchor.getAttribute('href')) {
            const tocItem = document.createElement('li');
            const link = document.createElement('a');
            link.textContent = headingAnchor.textContent || 'Untitled Section';
            link.href = headingAnchor.getAttribute('href');
            tocItem.appendChild(link);
            tocList.appendChild(tocItem);
        }
    });
});

// Hide TOC button initially
tocButton.style.display = 'none';

// Show/hide TOC button on scroll
window.addEventListener('scroll', () => {
    // Show button after scrolling down 200 pixels
    if (window.scrollY > 200) {
        tocButton.style.display = 'block';
    } else {
        tocButton.style.display = 'none';
        tocPanel.classList.remove('expanded');
    }
});

// Toggle TOC panel
tocButton.addEventListener('click', (event) => {
    event.stopPropagation(); // Prevent immediate closure
    tocPanel.classList.toggle('expanded');
});

// Close TOC panel when clicking outside
document.addEventListener('click', (event) => {
    if (tocPanel.classList.contains('expanded') && 
        !tocPanel.contains(event.target) && 
        event.target !== tocButton) {
        tocPanel.classList.remove('expanded');
    }
});


</script>

</body>
</html>
 
